Literature DB >> 2783346

Clinical manifestations of vaginal trichomoniasis.

P Wølner-Hanssen1, J N Krieger, C E Stevens, N B Kiviat, L Koutsky, C Critchlow, T DeRouen, S Hillier, K K Holmes.   

Abstract

Trichomonas vaginalis was detected by culture or wet-mount examination in 118 (15%) of 779 randomly selected women attending a sexually transmitted disease clinic. Vaginal trichomoniasis was significantly associated with symptoms of yellow discharge, abnormal vaginal odor, and vulvar itching and with signs of colpitis macularis ("strawberry cervix"), purulent vaginal discharge, and vaginal and vulvar erythema. A logistic regression model was used to adjust for coinfections, as well as for demographic, behavioral, and other possible confounding variables. Trichomonas vaginalis remained significantly associated with symptoms of yellow vaginal discharge (odds ratio [OR] = 2.4) and vulvar itching (OR = 3.0) and with signs of colpitis macularis (OR = 241), purulent vaginal discharge (OR = 8.0), vulvar erythema (OR = 2.5), and vaginal erythema (OR = 4.3). The sensitivity of symptoms and signs associated with trichomoniasis was relatively low. Nevertheless, clinical manifestations can be used to identify those patients for whom a wet-mount examination would likely have high yield. Careful clinical examination and selective use of wet-mount examination together with wider use of more sensitive tests for subclinical infection, such as culture or direct immunofluorescent staining of vaginal fluid, could lead to improved detection and control of this infection.

Entities:  

Mesh:

Year:  1989        PMID: 2783346     DOI: 10.1001/jama.1989.03420040109029

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  52 in total

1.  Delayed versus immediate bedside inoculation of culture media for diagnosis of vaginal trichomonosis.

Authors:  J R Schwebke; M F Venglarik; S C Morgan
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

2.  Viability of Trichomonas vaginalis in transport medium.

Authors:  A L Beverly; M Venglarik; B Cotton; J R Schwebke
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

3.  Bacterial Vaginosis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-02       Impact factor: 3.725

4.  Trichomonas vaginalis epidemiology: parameterising and analysing a model of treatment interventions.

Authors:  F J Bowden; G P Garnett
Journal:  Sex Transm Infect       Date:  2000-08       Impact factor: 3.519

5.  TV or not TV?

Authors:  A Smith; S Portsmouth; B Curran; D Warhurst; P Kell; N Saulsbury
Journal:  Sex Transm Infect       Date:  2002-06       Impact factor: 3.519

Review 6.  Trichomoniasis.

Authors:  Jane R Schwebke; Donald Burgess
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

7.  Diagnosis of Trichomonas vaginalis infection by PCR using vaginal swab samples.

Authors:  G Madico; T C Quinn; A Rompalo; K T McKee; C A Gaydos
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

Review 8.  Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis.

Authors:  Sarah L Cudmore; Kiera L Delgaty; Shannon F Hayward-McClelland; Dino P Petrin; Gary E Garber
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

Review 9.  Trichomonas vaginalis vaginitis in obstetrics and gynecology practice: new concepts and controversies.

Authors:  Jenell S Coleman; Charlotte A Gaydos; Frank Witter
Journal:  Obstet Gynecol Surv       Date:  2013-01       Impact factor: 2.347

10.  Detection of Trichomonas vaginalis on modified Columbia agar in the routine laboratory.

Authors:  Angelika Stary; Angelika Kuchinka-Koch; Lilianna Teodorowicz
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.